Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer
Background & Aims: Surgical resection is the only potentially curative therapy for patients with biliary tract cancer (BTC), but 5-year survival rates after tumor resection have remained below 30%, corroborating the need for better stratification tools to identify the ideal surgical candidates....
Main Authors: | Sven H. Loosen, Annemarie Breuer, Frank Tacke, Jakob N. Kather, Joao Gorgulho, Patrick H. Alizai, Jan Bednarsch, Anjali A. Roeth, Georg Lurje, Sophia M. Schmitz, Jonathan F. Brozat, Pia Paffenholz, Mihael Vucur, Thomas Ritz, Alexander Koch, Christian Trautwein, Tom F. Ulmer, Christoph Roderburg, Thomas Longerich, Ulf P. Neumann, Tom Luedde |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | JHEP Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555920300148 |
Similar Items
-
Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy
by: Sven H. Loosen, et al.
Published: (2021-04-01) -
Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis
by: Sven H Loosen, et al.
Published: (2021-03-01) -
Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma
by: Christoph Roderburg, et al.
Published: (2021-06-01) -
Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic Cancer
by: Sven H. Loosen, et al.
Published: (2019-01-01) -
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
by: Sven H Loosen, et al.
Published: (2019-01-01)